Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients with Stage III Soft Tissue Sarcomas of the Extremity By Ogkologos - December 2, 2024 1005 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SU2C-SARC032 study Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR Grieving for Your Old Life After Cancer September 10, 2020 Dad Creates Inclusive Children’s Book For Daughter With Disability And Others... January 25, 2022 “Nothing about us without us”: Why we’re working in partnership with... March 10, 2023 To Combat Cancer Treatment Resistance, Researchers Try Leveraging Evolution August 22, 2024 Load more HOT NEWS Middle Schooler Starts Business to Help Provide Spa and Salon Services... Cancer Moonshot℠ Workshop Highlights Recent Research Advances No Survival Benefit for Adding Adjuvant Chemotherapy to Endocrine Therapy in... Superior Prognostic Accuracy of Integrated 15-GEP/PRAME Classifier Over 15-GEP Alone in...
